Organization: Cyclica

Opinion Leader: Canada’s early focus on artificial intelligence is starting to reap commercial benefits

Canada’s early contributions and long-standing academic expertise in artificial intelligence are now generating growing funding for and revenue in AI in drug development, but the country’s AI-enabled drug development industry faces significant challenges in coming years, Dr. Ulrik Kristensen, PhD, founder and principal analyst at UK-based Emersion Insights, says in an op-ed.

The Short Report – April 28, 2021: COVID-19 data portal goes live, Protein Industries Canada launches new phase of plant-based food plan, Carleton funding bolsters ecosystem conservation, and more

Genome Canada’s portal for tracking variants of concern across Canada is up and running; a Carleton biology team gets support for bolstering ecosystem conservation; Protein Industries Canada starts the second phase of plans to boost plant-based foods, feed and ingredients; a briefing from the Royal Society of Canada calls on federal leadership to stabilize the postsecondary sector; and more.